Diabetes News and Research

Latest Diabetes News and Research

Nestlé, Biogaia sign new supplementary agreement

In February 2012 BioGaia sold the rights for the use of Lactobacillus reuteri Protectis in infant formula to Nestle for the remainder of the patent lifetime

12 Mar 2014

Researchers seek 400 treatment-naïve colon participants to measure non-invasive blood test

Investigators with Baylor Research Institute, a research arm of Baylor Scott & White Health, have opened participation for a new clinical trial that could determine whether a certain blood test can detect colon cancer before it even develops.

12 Mar 2014

PCORI to award $7 million contract to Chicago coalition to establish clinical data research network

On December 17, 2013, the Patient-Centered Outcomes Research Institute (PCORI) announced its intention to award an 18-month, $7 million contract to a Chicago area coalition of 20 health and hospital organizations including Loyola University Health System.

12 Mar 2014

Asian Diabetes Prevention Initiative website aims to put stop to type2 diabetes in Asia

The rapidly emerging diabetes epidemic in Asia has the potential to overwhelm health care systems, undermine economic growth, and inflict unprecedented levels of disability on the world's most populous continent.

12 Mar 2014

Novel approach to track Montreal consumers' food choices

Poor food choices, such as overconsumption of carbonated soft drinks, are an important factor driving the global obesity epidemic and have been linked directly to diabetes and heart disease. While public health agencies are working to help people to make healthier choices, monitoring the effectiveness of these efforts has been costly and difficult. But now, using the same digital data employed by marketers to promote food products, McGill University's David Buckeridge has developed a way for health agencies to track Montreal consumers' food choices, neighborhood by neighborhood.

11 Mar 2014

Monash University research offers new hope to people with heart attacks

Melbourne scientists are a step closer to creating a new drug to stop a heart attack in its tracks and reduce the damage caused, without any side effects.

11 Mar 2014

Aetna, Atlantic ACO announce new accountable care agreement

Aetna and Atlantic Accountable Care Organization, a partner of Atlantic Health System, today announced a new accountable care agreement that will improve the coordination and delivery of patient care. Atlantic ACO will deliver a better patient experience for more than 28,000 Aetna members in Morris, Sussex, Union, Somerset, Warren and Passaic counties.

11 Mar 2014

Hi-Tech Pharmacal's third fiscal quarter net sales decrease 7% to $59.9 million

Hi-Tech Pharmacal Co., Inc. today reported results for the third fiscal quarter ended January 31, 2014.

11 Mar 2014

MedVantx MedStart Connect program increases patient initiation of new prescriptions

New research presented today at the World Congress Summit to Improve Adherence and Enhance Patient Engagement by researchers from the University of Pittsburgh School of Pharmacy, finds that a unique generic medication sampling program, the MedVantx MedStart™ Connect program, implemented in the primary care physicians' office, led to significantly increased patient initiation of new prescriptions (primary adherence) as well as continued use of the medications (secondary adherence), and could possibly lead to savings for health plans.

11 Mar 2014

High antibody affinity identifies type 1 diabetes

LADA (latent autoimmune diabetes in adults) is a form of type 1 diabetes in adulthood. Like the childhood form, the insulin-producing beta cells of the pancreas are destroyed by the body's own immune system.

11 Mar 2014

Patients with metabolic syndrome are more likely to have complications after total joint replacement

In a new study presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), researchers found that total joint replacement patients with three or more metabolic syndrome risk factors were almost three times as likely to have complications within the first year after joint replacement.

11 Mar 2014

Total joint replacement may reduce risk for cardiac events and boost long-term survival

Hip and knee replacements have long been known to reduce pain and increase mobility in persons with moderate-to-severe arthritis. A study presented at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) also found that total joint replacement (TJR) may reduce the risk for "cardiac events," including heart attack and stroke, and boost long-term survival.

11 Mar 2014

Novel treatment strategy during transplantation surgery could spare patients from rejection

Organ-transplant recipients often reject donated organs, but a new, two-pronged strategy developed by UC San Francisco researchers to specifically weaken immune responses that target transplanted tissue has shown promise in controlled experiments on mice.

11 Mar 2014

Majority of Latinas unaware of diabetes risk

Approximately 5.5 million Latinas suffer from elevated fasting plasma glucose (FPG) and nearly 4 million of those women were never told by a healthcare provider they were at risk for diabetes, pre-diabetes, or were borderline for diabetes.

10 Mar 2014

Bosch Healthcare selects Brain Resource's MyBrainSolutions for use in telehealth solution

Brain Resource has announced today that Robert Bosch Healthcare Systems, Inc. (headquarters in Palo Alto, California, USA), the market leader in evidence-based telehealth solutions, has added MyBrainSolutions to their newly launched Health Buddy Web solution for the monitoring, education, and management of people living with chronic conditions.

10 Mar 2014

CSI's new Diamondback Peripheral 60cm systems receive FDA clearance for PAD treatment

Cardiovascular Systems, Inc., announced today it has received FDA clearance of its new Diamondback 360 60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

10 Mar 2014

Integrity Applications enters into distribution agreements for GlucoTrack device

Integrity Applications, Inc., developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into distribution agreements for the GlucoTrack device in Italy, Thailand and Uruguay.

10 Mar 2014

Research roundup: Health care and prisoners; hospitalized patients' surrogates; suicides in the army

As a group, jail-involved individuals, which we define here as people with a history of arrest and jail admission in the recent past, carry a heavy illness burden, with high rates of infectious and chronic disease as well as mental illness and substance use.

10 Mar 2014

Fibrotech successfully completes Phase Ia trial of anti-fibrotic compound FT011

Fibrotech, an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis, today announced that its lead anti-fibrotic compound FT011 has successfully completed a Phase Ia trial in healthy volunteers demonstrating safety and tolerability up to doses of 1000mg.

10 Mar 2014

Proteus Digital Health teams up with leading organisations to bring digital health technology to the UK

Leading digital medicines company Proteus Digital Health is partnering with Eastern Academic Health Science Network, The Northern Health Science Alliance and Oxford University, Oxford University Hospitals NHS Trust and Oxford Academic Health Science Network to bring digital health technology and global operations and manufacturing to the UK.

10 Mar 2014

Diabetes News and Research

Latest Diabetes News and Research

Nestlé, Biogaia sign new supplementary agreement

Researchers seek 400 treatment-naïve colon participants to measure non-invasive blood test

PCORI to award $7 million contract to Chicago coalition to establish clinical data research network

Asian Diabetes Prevention Initiative website aims to put stop to type2 diabetes in Asia

Novel approach to track Montreal consumers' food choices

Monash University research offers new hope to people with heart attacks

Aetna, Atlantic ACO announce new accountable care agreement

Hi-Tech Pharmacal's third fiscal quarter net sales decrease 7% to $59.9 million

MedVantx MedStart Connect program increases patient initiation of new prescriptions

High antibody affinity identifies type 1 diabetes

Patients with metabolic syndrome are more likely to have complications after total joint replacement

Total joint replacement may reduce risk for cardiac events and boost long-term survival

Novel treatment strategy during transplantation surgery could spare patients from rejection

Majority of Latinas unaware of diabetes risk

Bosch Healthcare selects Brain Resource's MyBrainSolutions for use in telehealth solution

CSI's new Diamondback Peripheral 60cm systems receive FDA clearance for PAD treatment

Integrity Applications enters into distribution agreements for GlucoTrack device

Research roundup: Health care and prisoners; hospitalized patients' surrogates; suicides in the army

Fibrotech successfully completes Phase Ia trial of anti-fibrotic compound FT011

Proteus Digital Health teams up with leading organisations to bring digital health technology to the UK

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in